Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Construction of Artificial Intelligence Recognition Model Based on Prospective Multidimensional Renal Transplant Pathology and Clinical Data for Accurate Differentiation of Rejection, Quantitative Lesion Assessment and Prediction of Re-recurrence Risk

NCT07741552 is registered in ClinicalTrials.gov with Chen Dajin as lead sponsor.

NCT NCT07741552
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07741552 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Construction of Artificial Intelligence Recognition Model Based on Prospective Multidimensional Renal Transplant Pathology and Clinical Data for Accurate Differentiation of Rejection, Quantitative Lesion Assessment and Prediction of Re-recurrence Risk
Lead sponsor
Chen Dajin
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2025
Completion date
October 31, 2030
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glomerulonephritis, graft rejection, kidney transplantation, polyomavirus infections